Thumbnail Image
Publication

Regulation of bone mass in endocrine diseases including diabetes

Higham, C.
; 
Abrahamsen, B.
Citations
Altmetric:
Abstract
Hormonal regulation plays a key role in determining bone mass in humans. Both skeletal growth and bone loss in health and disease is critically controlled by endocrine factors and low bone mass is a feature of both excess and deficiency of a broad range of hormones. This article explores the impact of diabetes and thyroid, parathyroid, sex steroid and growth hormone disorders on bone mass and fracture risk. Evidence for current management strategies is provided along with suggested practice points and gaps in knowledge for future research.
Authors
Higham, C.
Abrahamsen, B.
Affiliation
Christie Hospital NHS Foundation Trust, Manchester, UK; University of Manchester, Manchester, UK. Electronic address: claire.higham2@nhs.net. Open Patient Data Exploratory Network, Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Medicine, Holbæk Hospital, Holbæk, Denmark; NDORMS, University of Oxford, Oxford, UK. Electronic address: b.abrahamsen@physician.dk.
Description
Date
2022
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
From UNPAYWALL
Adobe PDF, 385.19 KB
Keywords
Type
Article
Citation
Higham C, Abrahamsen B. Regulation of bone mass in endocrine diseases including diabetes. Best Practice & Research Clinical Endocrinology & Metabolism. Elsevier BV; 2022. p. 101614.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/625078
Embedded videos